FRI-074-YI Rifaximin reduces healthcare utilization but not overall costs in patients with cirrhosis and recurrent episodes of hepatic encephalopathy: a retrospective efficacy study

Autor: van Doorn, Diederick, van Eekhout, Kirsi, de Wit, Koos, Baak, L.C., Klemt-Kropp, Michael, Verwer, Bart, Friederich, Philip W., de Bruin, Gijs J., Vos, Xander, Bart Takkenberg, R.
Zdroj: In Journal of Hepatology June 2024 80 Supplement 1:S213-S214
Databáze: ScienceDirect
Externí odkaz: